NEWPORT NEWS-Newport News-based ivWatch, LLC recently announced the appointment of Chris Pidgen to vice president of North American Sales.
In a release on March 3, the company announced that Pridgen’s medical sales background and knowledge will help drive growth in the U.S. and Canada. He will lead the sales and clinical specialist teams and report to ivWatch’s president and CEO, Gary Warren.
“Over the past three years, we have significantly bolstered our executive team and I am excited to have Chris join our team of experts,” Warren said. “The company is now perfectly primed for exponential growth in 2023 and beyond. Chris demonstrates a strong record of leadership and medical sales expertise that significantly strengthens our ability to further amplify our mission to help eliminate harm from IV infiltrations and extravasations.”
Prior to joining ivWatch, Pridgen spent 17 years at Medtronic.
ivWatch is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy.